Search Results
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
Search for other papers by Ariadni Spyroglou in
Google Scholar
PubMed
Search for other papers by Stylianos Kykalos in
Google Scholar
PubMed
Endocrine Unit, First Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Kosmas Daskalakis in
Google Scholar
PubMed
Search for other papers by Georgios Kyriakopoulos in
Google Scholar
PubMed
Search for other papers by Georgios C Sotiropoulos in
Google Scholar
PubMed
Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed
NET Unit, Royal Free Hospital, London, UK
Barts and the London School of Medicine, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
dedifferentiate during the course of the disease in different areas within the tumour at varying times, and that this process might represent different tumoural sub-clones. However, it is difficult to identify such an accumulation of genetic alterations in NEN
Instituto de Investigaciones Biomédicas ‘Alberto Sols’,, Servicio de Endocrinología y Nutrición,, Consejo Superior de Investigaciones Científicas y Universidad Autónoma de Madrid (CSIC-UAM), 28029 Madrid, Spain
Search for other papers by Garcilaso Riesco-Eizaguirre in
Google Scholar
PubMed
Search for other papers by Pilar Santisteban in
Google Scholar
PubMed
cell lines. In an attempt to investigate the overall occurrence of genetic alterations in the PI3K/Akt pathway in sporadic thyroid cancer, Hou et al . (2007) investigated the presence of PIK3CA copy number gain and mutation, RAS mutation and PTEN
Search for other papers by Avaniyapuram Kannan Murugan in
Google Scholar
PubMed
Search for other papers by Abeer Al-Amr in
Google Scholar
PubMed
Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Search for other papers by Mysoon M Al-Ansari in
Google Scholar
PubMed
Search for other papers by Pulicat S Manogaran in
Google Scholar
PubMed
Search for other papers by Hindi Al-Hindi in
Google Scholar
PubMed
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Search for other papers by Ali S Alzahrani in
Google Scholar
PubMed
, Europe, and East Asia. The incidence has increased annually at an average rate of 3.6%, while the annual mortality rate is increased at least 1.1% ( Morris et al. 2013 ). Genetic alterations in the MAPK (mitogen-associated protein kinase) and PI3K
Search for other papers by Valeria Coppola in
Google Scholar
PubMed
Department of Hematology, Department of Experimental Oncology, Oncology and Molecular Medicine, Istituto Superiore Sanità, viale Regina Elena 299, 00161 Rome, Italy
Search for other papers by Ruggero De Maria in
Google Scholar
PubMed
Search for other papers by Désirée Bonci in
Google Scholar
PubMed
been discussed above and is summarized in Table 1 . The following description includes miRs whose alterations have been correlated with genetic alterations and which eventually result in epigenetic reprogramming, miRs acting downstream of
Search for other papers by Jie Cai in
Google Scholar
PubMed
Search for other papers by Lin Li in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Xiaohua Jiang in
Google Scholar
PubMed
Search for other papers by Liyun Shen in
Google Scholar
PubMed
Search for other papers by Zhibo Gao in
Google Scholar
PubMed
Search for other papers by Weiyuan Fang in
Google Scholar
PubMed
Search for other papers by Fengjiao Huang in
Google Scholar
PubMed
Search for other papers by Tingwei Su in
Google Scholar
PubMed
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Search for other papers by Weiqing Wang in
Google Scholar
PubMed
School of Medicine, BGI-Shenzhen, Laboratory for Endocrine and Metabolic Diseases of Institute of Health Science, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University, #197 Ruijin 2nd Road, Shanghai 200025 People's Republic of China
Search for other papers by Guang Ning in
Google Scholar
PubMed
proliferation or phosphorylation of RET receptor was observed between the transfected cell lines ( Supplementary Fig. 3 , see section on supplementary data given at the end of this article). Discussion In this study we profiled genetic alterations in matched
Search for other papers by Roberto Bianco in
Google Scholar
PubMed
Search for other papers by Teresa Troiani in
Google Scholar
PubMed
Search for other papers by Giampaolo Tortora in
Google Scholar
PubMed
Search for other papers by Fortunato Ciardiello in
Google Scholar
PubMed
deletion in the extracellular domain that leads to constitutive activation of its tyrosine kinase (TK) domain, is the most frequently expressed EGFR genetic alteration in some cancers, like glioblastomas ( Nishikawa et al. 1994 , Moscatello et al. 1995
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Search for other papers by Eva-Maria Duerr in
Google Scholar
PubMed
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Search for other papers by Yusuke Mizukami in
Google Scholar
PubMed
Search for other papers by Aylwin Ng in
Google Scholar
PubMed
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Search for other papers by Ramnik J Xavier in
Google Scholar
PubMed
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Search for other papers by Hirotoshi Kikuchi in
Google Scholar
PubMed
Search for other papers by Vikram Deshpande in
Google Scholar
PubMed
Search for other papers by Andrew L Warshaw in
Google Scholar
PubMed
Search for other papers by Jonathan Glickman in
Google Scholar
PubMed
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Gastrointestinal Unit, Department of Medicine, Cancer Center, Center for Computational and Integrative Biology, Department of Surgery, Department of Pathology, Department of Adult Oncology
Search for other papers by Daniel C Chung in
Google Scholar
PubMed
/or metastases Any >30% Yes It is also uncertain how similar the genetic alterations are that underlie PNETs and GI-NETs, and whether they can be distinguished on a molecular level. Although there are important differences in their clinical behavior, they are
Search for other papers by Xuguang Zhu in
Google Scholar
PubMed
Search for other papers by Dong Wook Kim in
Google Scholar
PubMed
Search for other papers by Li Zhao in
Google Scholar
PubMed
Search for other papers by Mark C Willingham in
Google Scholar
PubMed
Search for other papers by Sheue-yann Cheng in
Google Scholar
PubMed
the thyroid tumors of the Thrb PV/PV mouse. Still, it is known that a reduced level of the PTEN gene due to methylation or other epigenetic silencing occurs in close association with activating genetic alterations of the PI3K-AKT pathway
Search for other papers by Sock Hoai Chan in
Google Scholar
PubMed
Oncology Academic Clinical Program, Duke-NUS Medical School Singapore, Singapore
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
Introduction Genomic instability is a hallmark of human cancers ( Negrini et al. 2010 ). It refers to the increased frequency of accruing genetic alterations, ranging from single nucleotide mutations to whole chromosome changes such as
Search for other papers by Christina M Knippler in
Google Scholar
PubMed
Search for other papers by Motoyasu Saji in
Google Scholar
PubMed
Search for other papers by Neel Rajan in
Google Scholar
PubMed
Search for other papers by Kyle Porter in
Google Scholar
PubMed
Search for other papers by Krista M D La Perle in
Google Scholar
PubMed
Search for other papers by Matthew D Ringel in
Google Scholar
PubMed
& Shah 2014 ). Unfortunately, these treatments only delay disease progression and/or induce transient partial remissions, highlighting the importance of new research in this area. Genetic alterations that result in enhanced activation of the MAPK and